TITLE

Lung deposition of colomycin depends on the nebuliser used

AUTHOR(S)
Simcock D
PUB. DATE
November 2003
SOURCE
Thorax;Nov2003, Vol. 58 Issue 11, p982
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
11582899

 

Related Articles

  • Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Byrne N M; Keavey P M; Perry J D; Gould F K; Spencer D A // Archives of Disease in Childhood;Aug2003, Vol. 88 Issue 8, p715 

    AIM: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis. METHODS: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with...

  • ATTEMPTED ERADICATION OF PSEUDOMONAS AERUGINOSA IN PATIENTS WITH NON-CYSTIC FIBROSIS BRONCHIECTASIS FOLLOWING INTRAVENOUS ANTIBIOTICS AND NEBULISED COLOMYCIN.  // Thorax;Dec2008 Supplement 7, Vol. 63, pA78 

    An abstract of the article "Attempted Eradication of Pseudomonas Aeruginosa in Patients With Non-Cystic Fibrosis Bronchiectasis Following Intravenous Antibiotics and Nebulised Colomycin," by J. Stowell and colleagues is presented.

  • Lung deposition after inhalation with various nebulisers in preterm infants. Köhler, E; Jilg, G; Avenarius, S; Jorch, G // Archives of Disease in Childhood;Jul2008 Supplement, Vol. 93 Issue 4, pF275 

    Aim: To compare pulmonary deposition after inhalation with three different nebulisers in preterm infants under conditions relevant to practice. Methods: The relative lung deposition (bioavailability) was estimated by inhalation of the marker substance, sodium cromoglycate (SCG), and measurement...

  • Lung deposition after inhalation with various nebulisers in preterm infants. E Köhler // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jul2008, Vol. 93 Issue 4, pF275 

    AIM: To compare pulmonary deposition after inhalation with three different nebulisers in preterm infants under conditions relevant to practice. METHODS: The relative lung deposition (bioavailability) was estimated by inhalation of the marker substance, sodium cromoglycate (SCG), and measurement...

  • The Treatment of Respiratory Pseudomonas Infection in Cystic Fibrosis: What Drug and Which Way? Banerjee, D.; Stableforth, D. // Drugs;Nov2000, Vol. 60 Issue 5, p1053 

    Pseudomonas aeruginosa is a non-capsulate and non-sporing Gram-negative bacillus that most commonly affects the lower respiratory system in humans. Burkholderia (previously Pseudomonas) cepacia has emerged as an important respiratory pathogen in patients with cystic fibrosis (CF). The ability of...

  • A trial of nebulised heparin to limit lung injury following cardiac surgery. Dixon, B.; Smith, R.; Santamaria, J. D.; Orford, N. R.; Wakefield, B. J.; Ives, K.; McKenzie, R.; Zhang, B.; Yap, C. H. // Anaesthesia & Intensive Care;2016, Vol. 44 Issue 1, p28 

    Cardiac surgery with cardiopulmonary bypass triggers an acute inflammatory response in the lungs. This response gives rise to fibrin deposition in the microvasculature and alveoli of the lungs. Fibrin deposition in the microvasculature increases alveolar dead space, while fibrin deposition in...

  • Nebulizer challenge.  // Pharmaceutical Technology Europe;Feb2006, Vol. 18 Issue 2, p14 

    The article reports that a dry powder inhalation formulation of the antibiotic Colomycin which is intended for cystic fibrosis (CF) patients whose lungs are infected by Pseudomonas aeruginosa, is being developed. The formulation being developed by Forest Laboratories had been granted orphan drug...

  • Colomycin.  // Royal Society of Medicine: Medicines;2002, p169 

    This article presents information on colomycin which is a proprietary, prescription-only preparation of the antibacterial and antibiotic colistin. It can be used by topical application to treat bacterial skin infections, and also by mouth and by injection for other purposes.

  • Lung aerosol deposition in suckling infants. Amirav, Israel; Luder, Anthony; Chleechel, Aidah; Newhouse, Michael T.; Gorenberg, Miguel // Archives of Disease in Childhood;Jun2012, Vol. 97 Issue 6, p497 

    Introduction Aerosol therapy in infants may be greatly compromised by face mask rejection due to squirming and crying. Lung aerosol deposition in crying infants may thereby be greatly reduced. Since 'suckling' on a pacifier calms infants, they should more readily accept a face mask that...

  • Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys. Marchand, Sandrine; Bouchene, Salim; Monte, Michèle; Guilleminault, Laurent; Montharu, Jérôme; Cabrera, Maria; Grégoire, Nicolas; Gobin, Patrice; Diot, Patrice; Couet, William; Vecellio, Laurent // Pharmaceutical Research;Oct2015, Vol. 32 Issue 10, p3403 

    Purpose: The objective of this study was to compare two different nebulizers: Eflow rapid® and Pari LC star® by scintigraphy and PK modeling to simulate epithelial lining fluid concentrations from measured plasma concentrations, after nebulization of CMS in baboons. Methods: Three baboons...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics